Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 17/20 | 1.00 |
| ▸ | ITGAV | P06756 | 17/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.47 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.47 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5494840 | 0.84 | ITGB3 (0.74) | ITGB3ITGAVITGA2B | |
| SCHEMBL7077881 | 0.83 | ITGB3 (0.73) | ITGB3ITGAVITGA2B | |
| SCHEMBL7091404 | 0.83 | ITGB3 (0.71) | ITGB3ITGAVITGA2B | |
| SCHEMBL7361495 | 0.82 | ITGB3 (0.69) | ITGB3ITGAVITGA2BPDK1PDK2 | |
| SCHEMBL5486017 | 0.79 | ITGB3 (0.65) | ITGB3ITGAVITGA2B | |
| SCHEMBL7095556 | 0.77 | ITGB3 (0.63) | ITGB3ITGAVITGA2B | |
| SCHEMBL14222778 | 0.77 | ITGB3 (0.62) | ITGB3ITGAVITGA2BPDK1PDK2 | |
| SCHEMBL7916989 | 0.74 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL6951971 | 0.74 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL8739838 | 0.74 | ITGB3 (0.79) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0910563-B1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | claimed |
| US-6008213-A | A INHIBITOR OF VITRONECTIN RECEPTOR AND FIBRINOGEN RECEPTOR; USEFUL FOR INHIBITING PLATELET AGGREGATION AND OSTEOPOROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-28 | — | — | US | claimed |
| EP-0910563-B1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6008213-A | A INHIBITOR OF VITRONECTIN RECEPTOR AND FIBRINOGEN RECEPTOR; USEFUL FOR INHIBITING PLATELET AGGREGATION AND OSTEOPOROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-28 | — | — | US | disclosed |